Matinas BioPharma to Present Company Replace and 2023 Enterprise Outlook on January 30, 2023

Matinas BioPharma Holdings, Inc. Convention name and dwell audio webcast scheduled for Monday, January thirtieth at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical firm centered on redefining the intracellular supply of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform expertise, at […]